ALB and diabetic kidney disease: To prevent such circumstances, RAAS inhibitors and Keto-analogs were recommended in clinical practice in treating DKD patients with nephrotic range proteinuria, since these could reduce the level of proteinuria and maintain the level of serum albumin [22,23] and delay renal function decline.